← Back to news

Markets

Billionaire Philipe Laffont Just Sold Coatue Management's Stake in Super Micro Computer and Piled Into Another Artificial Intelligence (AI) Giant Up Over 336,000% Since Its IPO

Y

3 Tech Stocks You Can Buy and Hold for the Next Decade

Y

1 Reason I Can't Take My Eyes Off of NuScale Power Stock in 2025

Y

Arizona man sick of running business but hesitates leaving $500K income — why Dave Ramsey says to get out ASAP

Y

Why Lumen Stock Surged This Week

Y

With the S&P 500 at Historically High Levels, This ETF Could Be the Best Way to Invest in the Index

Y

Yale’s Trendsetting Private-Equity Strategy Is Getting Harder to Pull Off

Y

The Middle-Class Vibe Has Shifted From Secure to Squeezed

Y

More Hong Kong small and medium-sized property developers to face default risks: experts

Y

Justin Sun eyes 'Swift' system for virtual asset sector, praises Hong Kong crypto progress

Y

Mortgage Rates Drop to 6% and Below — Should You Buy Now or Wait Until 2026?

Y

If You'd Invested $1,000 in ExxonMobil Stock 5 Years Ago, Here's How Much You'd Have Today

Y

How the Fed losing its independence could affect Americans’ everyday lives

Y

Could These 2 Stocks Surge 33% by 2026? A Deep Dive for Value Investors

Y

Can you afford to retire at this exact moment? Here are 3 simple rules of thumb to figure out if you can

Y

Africa Crypto News Week in Review: Mastercard Deal with Circle, InVastor Educational Program in Kenya, Interpol Crackdown in Angola and Zambia

Y

The Trumps’ New Crypto Money Maker: Deals With Themselves

Y

Prediction: This Unstoppable Stock Could Be the Next $2 Trillion Giant

Y

My 2 Favorite Stocks to Buy Right Now

Y

5 High-Yield Dividend Stocks I Plan on Holding for the Next 10 Years or Longer

Y

Netflix: Valuation, Sports, And Ongoing General Entertainment Excellence Make For A Precarious Balance

S

SentinelOne: Breakthrough AI Tech Could Change Cybersecurity

S

September Is the Worst Month for Stocks. This Year Might be Different.

Y

Hims & Hers Health: Still Undervalued

S

The J. M. Smucker Company (SJM) Just Doesn’t Have The Twinkies Pricing Power, Says Jim Cramer

Y

Abercrombie & Fitch Co. (ANF) Is A “Good Growth Company,” Says Jim Cramer

Y

Newmont Corporation (NEM) Is One Of The S&P 500’s Best Performing Stocks, Says Jim Cramer

Y

Novo Nordisk (NVO) Gains Momentum With Strong Earnings and Wegovy FDA Approval

Y

UBS Posts Solid Profit While Credit Suisse Integration Faces Regulatory Hurdles

Y

Novartis (NVS) Strengthens Outlook With Ianalumab Trial Success and Leqvio Expansion

Y

Ethereum: Large Catalysts To Drive The Next Leg Higher

S

One Liberty Properties: Huge Insider Ownership, Great Dividend Plus Turnaround Potential

S

WIW: Interest Rate Cuts Needed To Improve Dividend Coverage

S

Palomar Holdings: Running On All Cylinders, Buy The Correction

S

S&P 500 Snapshot: Inflation Worries Snap 3-Week Win Streak

S

HSBC Upgrades Eli Lilly (LLY) to Hold, Lifts Price Target to $700

Y

Oppenheimer Raises Price Target on Broadcom (AVGO) to $325, Maintains Outperform

Y

Analysts Maintain Confidence on Mastercard (MA) as Digital Payment Growth Fuels Momentum

Y

Alphabet (GOOGL) Deepens U.S. AI/Cloud Footprint with Virginia Expansion

Y

Piper Sandler Lifts PT on Amgen (AMGN) to $342 From $328, Keeps an Overweight Rating

Y

Bank of America Securities Reiterates a Hold Rating on PDD Holdings (PDD)

Y

BMO Capital Maintains a Hold on Bristol-Myers Squibb (BMY)

Y

Jefferies Reiterates a Buy Rating on CVS Health (CVS) With a PT of $80

Y

Gilead Sciences (GILD) Announces Marketing Authorization for Yeytuo from the European Commission

Y

UBS Raises PT on ConocoPhillips (COP) to $123 From $116

Y

Pfizer (PFE) Announces FDA Approval of sBLA for Pfizer-BioNTech COVID-19 Vaccine

Y

Bank of America Securities Remains Bullish on AT&T Inc. (T)

Y

What Do Analysts Think About Verizon Communications (VZ)?

Y

What Does Wall Street Think About BioMarin Pharmaceutical (BMRN)?

Y

H.C. Wainwright Lifts PT on Summit Therapeutics (SMMT) to $50 From $44

Y